STOK: Ticho Barry discloses a sale

By AlphaYouPublished Oct 2, 2026Form 4

Stocks in this disclosure

Reported activity

Ticho Barry

Reporting filer

Ticho Barry reported Sale in Stoke Therapeutics, Inc.: 1051 units of Common Stock, dated 2026-10-01. The full Form 4 contains 1 transaction entry.

Disclosed: Oct 2, 2026

Reported details

1 entry

All validated entries in this disclosure
Security	Owner	Date	Code	Action	Quantity	Price	Following holdings	Reporting delay	Filed terms and references
Common Stock	Ticho Barry	2026-10-01	S	Sale	1051	26.1594	19,059	1 day	Filed terms security Title: Common Stock transaction Date: 2026-10-01 transaction Form Type: 4 transaction Code: S equity Swap Involved: 0 id: F1 transaction Shares: 1051 transaction Price Per Share: 26.1594 id: F2 transaction Acquired Disposed Code: D shares Owned Following Transaction: 19059 direct Or Indirect Ownership: D nature Of Ownership:

Common Stock

Owner: Ticho Barry
Date: 2026-10-01
Code: S
Action: Sale
Quantity: 1051
Price: 26.1594
Following holdings: 19,059
Reporting delay: 1 day
Filed terms and references: Filed terms
security Title: Common Stock
transaction Date: 2026-10-01
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F1
transaction Shares: 1051
transaction Price Per Share: 26.1594
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 19059
direct Or Indirect Ownership: D
nature Of Ownership:

Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.
Ticho Barry: CHIEF MEDICAL OFFICER.
The filing reports a Rule 10b5-1 trading plan.
F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025.
F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.91 to $26.51 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Original sources

SEC ownership filing

Prepared automatically from public filing data. Report a correction.

Security

Owner

Date

Code

Action

Quantity

Price

Following holdings

Reporting delay

Filed terms and references

Common Stock

Ticho Barry

2026-10-01

Sale

1051

26.1594

19,059

1 day

Filed terms

security Title: Common Stock
transaction Date: 2026-10-01
transaction Form Type: 4
transaction Code: S
equity Swap Involved: 0
id: F1
transaction Shares: 1051
transaction Price Per Share: 26.1594
id: F2
transaction Acquired Disposed Code: D
shares Owned Following Transaction: 19059
direct Or Indirect Ownership: D
nature Of Ownership:

Filing context

Quantities and prices are shown in the units filed. No trade value is inferred from their product.

Ticho Barry: CHIEF MEDICAL OFFICER.

The filing reports a Rule 10b5-1 trading plan.

F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025.

F2: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.91 to $26.51 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.